Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 55
- Reported
- 52
- Verified
- 46
- Gap
- +9
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Track; not yet
- Why
- Genuinely novel first-in-human clinical proof of direct cccDNA epigenetic silencing is a real milestone, but it remains early-phase with single-digit denominators, no cure endpoint met, and unproven long-term durability.
- Next
- Monitor the planned late-2026 Phase 2 readout for actual HBsAg seroclearance rates and longer durability before treating epigenetic silencing as a validated modality.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 3
- Tier 3
- 4
- Supports
- 3
- Contradicts
- 2
- Context
- 2
- Latest observed
- 2026-05-30
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.